10h
Zacks Investment Research on MSNVertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for InvestorsIn the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $502.55, marking a +0.45% move from the previous day. The stock's change was more than the S&P 500's daily loss of 0.33%. At the ...
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results